Biomark Diagnostics Company Description

Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer.

The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer.

It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers.

The company was incorporated in 2014 and is headquartered in Richmond, Canada.

Biomark Diagnostics Inc.

Country	Canada
Founded	2014
Industry	Diagnostics & Research
Sector	Healthcare
CEO	Rashid Ahmed Bux

Contact Details

Address: 3851 Shell Road Richmond, British Columbia V6X 2W2 Canada
Phone	604 370 0779
Website	biomarkdiagnostics.com

Stock Details

Ticker Symbol	BUX
Exchange	Canadian Securities Exchange
Fiscal Year	April - March
Reporting Currency	CAD
ISIN Number	CA09073K1084
SIC Code	2836

Key Executives

Name	Position
Rashid Ahmed Maula Bux B.Sc., MBA	Founder, Chief Executive Officer, President and Director
Guoyu Huang MBA	Chief Financial Officer
Brian Kai-Ming Cheng B.Sc., M.Sc, M.Sc.	Chief Technical Officer and Independent Director
Dr. Jeff Haince Ph.D.	GM and Chief Scientific Officer